DOI QR코드

DOI QR Code

Cervical Cancer Trends in Mexico: Incidence, Mortality and Research Output

  • Anaya-Ruiz, Maricruz (Laboratory of Cellular Biology, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social) ;
  • Vincent, Ana Karen (Laboratory of Cellular Biology, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social) ;
  • Perez-Santos, Martin (Vice-rectory of Research and Postgraduate Studies, Benemerita Universidad Autonoma de Puebla)
  • Published : 2014.11.06

Abstract

Purpose: To evaluate the recent incidence and mortality of and scientific research trends in cervical cancer in Mexican females. Materials and Methods: Data between 2000 and 2010 from the Department of Epidemiology of the Ministry of Health, and International Agency for Research on Cancer (IARC) of World Health Organization were analyzed, and age-standardized rates (ASRs) were calculated. In addition, scientific research data were retrieved from the Web of Science database from 2003 to 2012, using different terms related to cervical cancer. Results: The incidence rate decreased during last five years, while mortality rates showed an annual decrease of 4.93%. A total of 780 articles were retrieved, and the institutions with the majority of publications were National Autonomous University of Mexico (34.87%), Social Security Mexican Institute (16.02%), and National Institute of Cancerology (15%). The main types of research were treatment, diagnosis, and prevention. Conclusions: The above results show that incidence of cervical cancer decreased over time in Mexico during last five years; similarly, the downturn observed in mortality mainly reflects improved survival as a result of earlier diagnosis and cancer treatment. Also, this article demonstrates the usefulness of bibliometrics to address key evaluation questions and to establish priorities, define future areas of research, and develop cervical cancer control strategies in Mexico.

Keywords

Cervical cancer;incidence;mortality;bibliometric;control strategies;Mexico

References

  1. Adegoke O, Kulasingam S, Virnig B (2012). Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Health, 21, 1031-7. https://doi.org/10.1089/jwh.2011.3385
  2. Dursun P, Gultekin M, Ayhan A (2011). World gynecologic oncology publications and the Turkish contribution to the literature between 2000 and 2007. Asian Pac J Cancer Prev, 12, 861-4.
  3. Andrae B, Andersson TM, Lambert PC, et al (2012). Screening and cervical cancer cure: population based cohort study. BMJ, 344, 900. https://doi.org/10.1136/bmj.e900
  4. Arbyn M, Castellsague X, de Sanjose S, et al (2011). Worldwide burden of cervical cancer in 2008. Ann Oncol, 22, 2675-86. https://doi.org/10.1093/annonc/mdr015
  5. Conde-Ferraez L, Suarez Allen RE, Carrillo Martinez JR, Ayora-Talavera G, del Gonzalez-Losa M R (2012). Factors associated with cervical cancer screening amongst women of reproductive age from Yucatan, Mexico. Asian Pac J Cancer Prev, 13, 4719-24. https://doi.org/10.7314/APJCP.2012.13.9.4719
  6. Fajardo-Ortiz D, Ochoa H, Garcia L, Castano V (2014). Translation of knowledge on cervical cancer: is there a gap between research on causes and research on patient care? Cad. Saude Publica, Rio de Janeiro, 30, 415-26.
  7. Gonzaga CM, Freitas-Junior R, Barbaresco AA, et al (2013). Cervical cancer mortality trends in Brazil: 1980-2009. Cad Saude Publica, 29, 599-608. https://doi.org/10.1590/S0102-311X2013000300017
  8. Guler T, Yayci E, Atacag T, Cetin A (2013). An analysis of Turkey's scientific contribution in ovarian cancer research. Eur J Gynaecol Oncol, 34, 175-8.
  9. Ho YS, Satoh H, Lin SY. (2010). Japanese lung cancer research trends and performance in Science Citation Index. Intern Med, 49, 2219-28. https://doi.org/10.2169/internalmedicine.49.3687
  10. Ito K, Tsunematsu M, Satoh K, Kakehashi M, Nagata Y (2013). Effectiveness of cervical cancer screening based on a mathematical screening model using data from the Hiroshima Prefecture Cancer Registry. Asian Pac J Cancer Prev, 14, 4897-902. https://doi.org/10.7314/APJCP.2013.14.8.4897
  11. Jung KW, Won YJ, Kong HJ, et al (2014). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat, 46, 109-123. https://doi.org/10.4143/crt.2014.46.2.109
  12. Mayta-Tristan P, Huamani C, Montenegro-Idrogo JJ, Samanez-Figari C, Gonzalez-Alcaide G (2013). Scientific production and cancer-related collaboration networks in Peru 2000-2011: a bibliometric study in Scopus and Science Citation Index. Rev Peru Med Exp Salud Publica, 30, 31-6. https://doi.org/10.1590/S1726-46342013000100006
  13. Kim MH, Song YM, Kim BK, Park SM, Ko GP (2013). Trends in cervical cancer mortality by socioeconomic status in Korean Women between 1998 and 2009. Korean J Fam Med, 34, 258-64. https://doi.org/10.4082/kjfm.2013.34.4.258
  14. Lazcano-Ponce E, Allen B, Palacio-Mejia LS, Hernandez-Avila M (2006). Challenges to implement strategies for the primary and secondary prevention of cervical cancer in Mexico. Gac Med Mex, 142, 43-9.
  15. Lazcano-Ponce E, Salmeron-Castro J, Garcia-Carranca A, et al (2009). Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization. Salud Publica Mex, 51, 336-41. https://doi.org/10.1590/S0036-36342009000400011
  16. Micheli A, Di Salvo F, Lombardo C, et al (2009). Italian performance in cancer research. Tumori, 95, 133-41.
  17. Mosavi-Jarrahi A, Kliewer EV (2013). Cervical cancer incidence trends in Canada: a 30-year population-based analysis. J Obstet Gynaecol Can, 35, 620-26.
  18. Munoz N, Bravo LE (2012). Epidemiology of cervical cancer in Colombia. Colomb Med, 43, 298-304.
  19. Nessa A, Nahar KN, Begum SA, et al (2013). Comparison between visual inspection of cervix and cytology based screening procedures in Bangladesh. Asian Pac J Cancer Prev, 14, 7607-11. https://doi.org/10.7314/APJCP.2013.14.12.7607
  20. Parikh S, Brennan P, Boffetta P (2003). Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer, 105, 687-91. https://doi.org/10.1002/ijc.11141
  21. Perez-Santos JL, Anaya-Ruiz M (2013). Mexican breast cancer research output, 2003-2012. Asian Pac J Cancer Prev, 14, 5921-3. https://doi.org/10.7314/APJCP.2013.14.10.5921
  22. Vidal C, Hoffmeister L, Biagini L (2013). Trend in cervical cancer mortality in Chile: application of joinpoint regression models. Rev Panam Salud Publica, 33, 407-13.
  23. Raychaudhuri S, Mandal S (2012). Current status of knowledge, attitude and practice (KAP) and screening for cervical cancer in countries at different levels of development. Asian Pac J Cancer Prev, 13, 4221-7. https://doi.org/10.7314/APJCP.2012.13.9.4221
  24. Ruiz-Moreno JA, Ponce EL, Vargas-Hernandez VM, et al (2011). Consensus for the prevention of cervical cancer in Mexico. Ginecol Obstet Mex, 79, 785-7.
  25. Simayi D1, Yang L, Li F, et al (2013). Implementing a cervical cancer awareness program in low-income settings in Western China: a community-based locally affordable intervention for risk reduction. Asian Pac J Cancer Prev, 14, 7459-66 https://doi.org/10.7314/APJCP.2013.14.12.7459

Cited by

  1. Knowledge, Attitudes and Practice about Pap Smear Test among Women Living in Bojnourd, North East of Iran: a Population-Based Study vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.2013
  2. Causative agents, diseases, epidemiology and diagnosis of sexually transmitted infections vol.28, pp.1, 2017, https://doi.org/10.1097/MRM.0000000000000089